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ABSTRACT
Urinary Tract Infection is alarming problem worldwide due to the intensity of antimicrobial
resistance. Escherichia coli is the most predominant organism in UTI. This study was
planned to evaluate demographic parameters, the prevalence of E. coli, and antimicrobial
resistance patterns among E. coli isolates from UTI patients in Nishtar Hospital of Multan
from January to June 2018. A total of 350 mid-stream urine samples were collected from
different patients having age group from 25 to 60 years and processed by standard laboratory
procedures. Out of 350 samples, 100 samples were observed as critical bacteremia.
Escherichia coli and Klebsiella pneumonia were the most persistent (47 % and 19 %
individually) among the Gram-negative pathogens followed by S. aureus (14 %),
Enterobacter spp. (11 %) and Candida (9 %) respectively. The incidence of UTI was found
higher in 25-35 age groups. The prevalence of UTI with E. coli as an infectious agent was 72
% in females, and 28 % in males. The prevalence of E. coli was more in rural areas (70 %)
than in urban areas (26 %). The antimicrobial testing against E. coli showed the highest
resistance to amoxicillin (65.9 %) and ciprofloxacin (38.2 %), whereas highly sensitive rate
observed against Fosfomycin (FOS) (95.7 %), Gentamicin (GEN) (89.3 %), and
Nitrofurantoin (NIT) (85 %) respectively. The increased resistance against ampicillin and
ciprofloxacin was observed in Multan have a great emerging problem so there is a need for
effective prevention strategies for the E. coli drug resistance and successful surveillance
required to be improved.
Keywords: Urinary Tract Infection, prevalence, escherichia coli, resistance, antibiotics.
INTRODUCTION
Urinary tract infection is the most
familiar microbial disease especially
present in hospitals and communities
affecting people of all age groups (Rosen
et al., 2007). The occurrence of urinary
tract disease depends upon little variables
that give the proximity of minute
organisms (more than 105/ ml) in urine
samples (Mihankhah et al., 2017). Every
year, 150 million individuals are
influenced by UTI around the world
(Shabbir, 2017). UTI is considered as the
second most common cause of contagions
(Klumpp et al., 2006). The prevalence of
UTI is found in both genders while the

frequency is higher in females than in
males and there is a 50 to 70% chance that
every woman will at least acquire one UTI
during her lifetime (Wiedemann et al.,
2014) While UTI is not common in men
but it can be very severe when it happens
(Elahe, 2015). The UTIs is affected by
other risk factors like age, gender, sexual
behavior, immunity, diabetes, and
neurological diseases (Hsueh, 2011).
The most causative agent of the
UTI is E. coli and this bacterium is
responsible for different cases of these
infections (Daza et al., 2001). Among the
uropathogenic and nosocomial UTI, E. coli
is the most predominant pathogen
(Shatalov, 2015). Moreover, E. coli is the
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cause of emergency clinically gained UTI
(De Cueto & Aliaga, 2016). The microbial
spectrum that is often isolated from urine
samples
is
Escherichia
coli,
Staphylococcus aureus, Enterococcus,
Proteus sp., Candida albicans, and
Klebsiella pneumonia,
Pseudomonas
aeruginosa (Bronsema et al., 1993).
In developing countries, antibiotic
resistance is the major public health issue
to treat such kind of infections because of
the fast spread of mutant strains antibiotics
fail to work against these drug resistance
mutated pathogens. Thus, it complicates
the treatment of UTI (Kibret and Abera,
2011). UTIs influenced the nature of
infected people and it becomes the reason
for increasing monetary and common wellbeing loads. Patients with UTI are treated
with anti-infectious agents. Anti-toxins
that are used as medicine can be a result of
the transformation of the microbial flora of
the vagina and gastrointestinal tract. It
involves the improvement of multidrugsafe microorganisms (Kostakioti et al.,
2012). The cure for UTIs is getting to be
hard because of the development of the
anti-toxin barrier mechanism (Hooton,
2012).
Increased
resistance
to
antimicrobial agents makes it difficult to
manage the UTIs (Mandal et al., 2012). In
E. coli, the emerging resistance may be
due to the chromosomal transformation,
transportation of the resistant genes that
make it resistant to generally used drug
and it becomes MDR (Dever and
Dermody, 1991).
To overcome the problem of
emerging MDR uropathogens, the
epidemiological surveillance data can be
obtained from different hospitals and
analyzed truly. The anti-microbial agents
should be prescribed after cultural
investigation according to the guidelines
"Infectious Diseases Society of America"
(Khawcharoenporn et al., 2013).
Thus, the present study aimed to
isolate the most infectious agent of UTI
according to their demographic parameters
like age, gender, location and check the

susceptibility pattern of UTI’s causative
agent to different anti-microbial agents
among patients that referred to different
wards of Nishtar Medical Hospital and
University, Multan.
MATERIAL AND METHODS
Study Area and Period
A cross-sectional study was
conducted at Nishtar Medical University
and Hospital, Multan for a period of six
months (from January 2018 to June 2018).
Ethical Approval
The study plan was approved from
Ethical committee of Nishtar Medical
University and Hospital, Multan, prior to
execution of the research.
Demographic Parameters of the Study
During this time of six months,
samples were obtained from patients with
their consent having symptoms of UTI.
Demographic parameters such as age,
gender, residency was also collected from
all the patients of gynaecology, general
medicine, urology, and surgery ward.
Sample Collection and Nature of the
Sample
A total of 350 mid-stream urine
samples were collected in sterilized plastic
containers and transported to the
laboratory
immediately
to
avoid
contamination and further processing to
determine the presence of E. coli in urine
samples. The nature of the urine samples
was different from patient-to-patient
situation according to their diseases like
diabetes, renal diseases, pregnancy,
catheterization, and surgical site infection.
They were all susceptible to urinary tract
infection. The results were recorded
according
to
standard
protocols
(Aghazadeh et al., 2015)
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Isolation and Identification of E. coli

RESULTS

For isolation of bacteria, culturing
of about 0.001 mL of urine samples on the
Cystine
Lactose-Electrolyte-Deficient
Agar (CLED agar) was done with the help
of a calibrated loop. The samples were
incubated overnight at 37 °C. The
selection of media was based on the
desired organism which could be capable
to grow on it (Kiffer et al., 2007; AlBenwan et al., 2010).
After culturing, the Gram staining
technique was used to differentiate
between Gram-Negative and GramPositive Bacteria. Further biochemical
testing such as TSI citrate, indole, motility,
catalase and oxidase tests were performed
to identify the presence of desired bacteria
in the dissimilar bacterial colony (Holt et
al., 1994; Washington, 2012).

Prevalence of E. coli and other Isolates of
Bacteria in UTI Patients
A total of 350 urine samples were
analyzed from different patients of Nishtar
Medical University and Hospital during
the period of six months from January
2018 to June 2018. Out of 350 urine
samples, 100 (28.57 %) of samples
showed bacteremia. As shown in Table 1,
the prevalence of E. coli was observed
high 47(47 %) out of 100 growing cultures
(N=100) as compared to other isolates
such as K. pneumonia 19 (19 %), S. aureus
14(14%), Enterobacter 11(11 %) and
Candida 9 (9 %). N showed the total
number of growing cultures.
Table 1: Distribution of isolated strains from
UTI patients (N=100).

Antimicrobial Susceptibility Testing

Isolates

After the identification of E. coli,
antimicrobial susceptibility testing was
performed on Muller Hinton Agar with the
help of Kirby–Bauer disc diffusion method
(Hudzicki 2009). The antibiotics such as
Amikacin (AK), Tazobactam/Piperacillin
(TPZ), Nitrofurantoin (NIT), Colistin
(CT/CST), Ciprofloxacin (CIP), Imipenem
(IMP),
Amoxicillin
(AMX/AML),
Fosfomycin (FOS), Gentamicin (GEN)
and Tetracycline (TCN/TET) were used to
obtain
profiles
of
antimicrobial
susceptibility. The results were interpreted
according to the guidelines of CLSI
criteria (Clinical and Laboratory Standards
Institute) (Balouiri et al., 2016).

E.coli
K. pneumonia
S. aureus
Enterobacter
Candida
Total

Statistical Analysis
All the categorical data was
cleaned in MS Excel and all analysis were
carried out with the help of XL-stat
software 2010. All analysis was performed
to investigate the prevalence of E. coli as
an infectious agent of UTI patients in
Multan.

Percentage of
Isolates
47 %
19 %
14 %
11 %
09 %
100 %

Prevalence of E. coli in Demographic
Parameters
The data were categorized according to
age, gender, marital status, and types of
residency.
Patients
from
different
departments of Gynaecology, General
Medicine, Urology, and Surgery were
analyzed. The prevalence of UTIs with
positive culture was observed in these
departments. The maximum number of
cases was found in Gynecology 39 (39 %).
followed by General Medicine 32 (32 %),
Urology 18 (18 %), and surgery 11(11 %)
in UTI (Table 2).
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For age distribution, patients were divided
into different categories of age: 25-35, 35 45, 45 -55 and > 55 years. Out of 100
positive cases, 72 were females and 28
were males.
Table 2: Prevalence of UTI in different wards
(N=100).

Departments

%age

Gynecology
General Medicine
Urology
Surgery
Total

39%
32%
18%
11%
100%

The highest occurrence of UTI
patients was found in the age group of 2535 followed by 35 - 45, 45 - 55 and > 55
years respectively. In both females and
males, the prevalence of UTI was observed
higher in the age group of 25-35 followed
by 35 - 45, 45-55 and > 55 years. The
females (52.7 %) were more infected in
their reproductive age group 25 - 35 as
compared to males (50 %) (Table 3).

Table 3: Prevalence of UTI in different age
groups in both males and female (N=100).

Ages
25-35
35-45
45-55
>55

Male
14
10
3
1

% age
50%
35.7%
10.7%
3.57%

Female
38
13
11
10

% age
52.7%
18.0%
15.2%
13.8%

In demographic parameters, the
prevalence of E. coli as an infectious agent
of UTI was analyzed. Out of 100 positive
samples, 47 samples were found with E.
coli. About 13 (28 %) were males and 34
(72 %) were females found to be infected
with E. coli as the main cause of UTI. A
high prevalence of E. coli was observed in
married patients 28 (60 %) rather than
single patients 19 (40 %). In the same way,
the occurrence of E. coli was relatively
high in rural areas 33(70 %) than the urban
areas 12(26 %) as described in Table
4.This difference may be due to the use of
unhygienic food, less access to health care,
and other socioeconomic factors.

Table 4: Demographic distribution of subjects in UTI patients with E. coli positive.

Gender

Number of Patients
13
34

Total E.coli
Positive Cases
47
47

Prevalence %
(E. coli +)
28%
72%

Males
Females
Marital status
Single
Married
Types of Residency
Urban
Rural

19
28

47
47

40%
60%

12
33

47
47

26%
70%

Antimicrobial Screening
Strains of E. coli

of

Isolated

In this present study, only the
antibiotic susceptibility pattern of E. coli
was analyzed. Ten antibiotic discs
amikacin (AK), tazobactam/piperacillin
(TPZ), nitrofurantoin (NIT), colistin (CT),
imipenem (IMP), ciprofloxacin (CIP),
amoxicillin (AML), fosfomycin (FOS),
gentamicin (GEN) and tetracycline (TET)

were used. According to their zone of
inhibition, all the drugs have different
resistant, intermediate and sensitive
patterns. The antimicrobial susceptibility
profile of E. coli against these drugs is
presented in Table 5. In the present study,
the percentages of isolated E. coli were
mostly resistant to these drugs amoxicillin
(AMX/AML) 65.9 %, ciprofloxacin (CIP)
38.2 %, colistin (CT/CST) 27.6 %
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% age

respectively and these drugs were not
considered to be very effective against
UTI treatment. E. coli have been found
highly sensitive to Fosfomycin (FOS) 95.7
%, Gentamicin (GEN) 89.3
%,
Nitrofurantoin
(NIT)
85
%,

Tazobactam/Piperacillin (TPZ) 78.7 %,
Amikacin (AK) 74.4 %, Tetracycline
(TCN/TET) 70.2 %, and very less
sensitive to imipenem (IMP) 68 % (Figure
1 and Table 5).

120
100
80
60
40
20
0

Resistant

Intermediate

Susceptible

Figure 1: Resistance-wise distribution (%) of E. coli isolates with different antibiotics as resistant,
intermediate and sensitive.
Table 5: Profile of antimicrobial susceptibility testing.
Antibiotics
Total
Resistant
isolates
(%)
(E. coli)
Amikacin (AK)
47
10 (21.2)
Tazobactam/Piperacilin (TPZ)
47
1 (2.1)
Nitrofurantoin (NIT)
47
5 (10.6)
C0listin (CT/CST)
47
13 (27.6)
Ciprofloxacin (CIP)
47
18 (38.2)
Imipenem (IMP)
47
8 (17.0)
Amoxicillin (AMX/AML)
47
31 (65.9)
Fosfomycin (FOS)
47
2 (4.2)
Gentamicin (GEN)
47
3 (6.3)
Tetracycline (TCN/TET)
47
9 (19.1)

DISCUSSION
In therapeutic management of
UTIs, the advanced knowledge on the
prevalence and antibiotic susceptibility
pattern of pathogenic bacteria is very
necessary which serves as an infectious
agent of UTIs. The number of virulence
factors
such
as
capsule,
lipopolysaccharide, flagella, fimbriae,
toxins, and iron scavenger receptors
associated with different types of
uropathogenic Escherichia coli (UPEC) is
concerned to cause UTIs (Karam et al.,

Intermediate
(%)

Sensitive
(%)

2 (4.2)
9 (19.1)
2 (4.2)
4 (8.5)
0 (0.0)
7 (14.8)
4 (8.5)
0 (0.0)
2 (4.2)
5 (10.6)

35 (74.4)
37 (78.7)
40 (85)
30 (63.8)
31(65.9)
32 (68.0)
12 (25.5)
45 (95.7)
42 (89.3)
33 (70.2)

2019). The present study showed that the
prevalence of Gram-Negative bacteria 77
% was high as compared to other GramPositive bacteria (14 %). E. coli was the
most dominant among the Gram-Negative
bacteria 47 % than the K. pneumonia 19
%. The results of this study were
supported by the previous study of
(Elmanana` et al., 2018) which showed
that E. coli was in higher number as
compared to other isolates. Other previous
studies revealed the higher frequency of E.
coli (i.e. 70 %) followed by K. pneumonia
11 % (Noor et al., 2013). This shows the
most powerful evidence that E. coli is the
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most common and predominant pathogen
in UTIs, similar findings have been
observed in the past (Sabir et al., 2014).
In our study, the UTI patients
associated
with
the
Gynecology
department were higher in number. It was
concluded that women were greater in
number as compared to men associated
with other departments. The chances of
UTI increase during pregnancy. This study
supported by the previous study by Pallet
(Pallet and Hand, 2010). This study shows
that the prevalence of UTI was very high
in Females 52.7 % in their reproductive
age group 25-35 as compared to males 50
%. A previous study, Bari et al, (2017)
revealed higher number of female patients
in their reproductive age are being affected
by UTI (Bari et al., 2017). In our study, the
prevalence of E. coli in UTI patients was
very high in females about 72 % as
compared to males 28 %. A number of
studies reported the prevalence of E. coli
in UTI patients very high in females than
in males (Okonko et al., 2009; Martin et
al., 2019). This may happen due to the
colonization of the vagina with coliforms
with the help of vaginal microflora which
can be associated with UTIs (Hooton and
Stamm, 1997). Furthermore, females have
the short urethral tube so that bacteria can
easily access to the bladder to cause
infections. These factors of causing UTI
are accelerated by low soci-economic
status, sexual behavior, and the use of
unhygienic food (Nas et al., 2019).
The location and socioeconomic
status may contribute to the development
of UTI with E. coli because several UTI
patients belonged to rural areas (70 %) and
less from urban areas (26 %). This
happens due to less access to pure water,
the use of unhygienic food, and poor living
condition. Present study findings are in
line with Dhodhi et al., (2014). Resistance
to antibiotics is increasing day by day and
it leads to becoming a world-wide problem
(Sefton, 2000). According to this study,
the prevalence of higher resistance rate
was observed to Amoxicillin (65.9 %) and

ciprofloxacin (38.2 %) which cannot be
used for the treatment of UTI in that
particular area of study. Higher sensitivity
rates were detected to antibiotics such as
Fosfomycin (95.7 %), Gentamicin (89.3
%),
Nitrofurantoin
(85
%)
and
Tazobactum (78.7 %). According to the
findings, which have been reported in
previous studies carried out in Ethiopia,
Iran respectively (Moges, et al., 2002;
Farajnia et al., 2009; Beyene and Tsegaye,
2011) and in Kosovo (Raka et al., 2004),
Ciprofloxacin has great susceptibility
against E. coli but in our study, E. coli
have greater resistance against this
antibiotic. This increased resistance in
strains may be due to the geographical
changes in Multan because most of the
people belong to less developed areas and
excessive use of antibiotics without any
microbial investigation might be the
reason for resistance against antibiotics.
It should be needed to minimize
the rising resistance in E. coli from UTI
patients by increasing knowledge about
some necessary measurements by the
healthcare professionals such as antibiotics
should be prescribed after microbial
investigation and there should be the
presence of infection control strategies to
decrease the hazard of future resistance to
antimicrobial agents.
CONCLUSION
Studies revealed the re-emergence
resistance of E. coli against several
antibiotics makes it difficult to treat
patients with UTI. It is very difficult to
treat these infections in developing
countries due to the financial burden on
the health care system. Proper guidelines
for the regular surveillance for sensitivity
pattern of antibiotics are very necessary
for the management of UTIs. Therefore,
routine sensitivity screening of antibiotics
should be carried out before the
prescription is recommended. This will
help in designing the emerging multidrug
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resistance problem to the frequently used
antibiotics.
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